Holyoake, D L P <br/><br/>
Stomach Dose-Volume Predicts Acute Gastrointestinal Toxicity in Chemoradiotherapy for Locally Advanced Pancreatic Cancer.  [electronic resource] 

 -  Clinical oncology (Royal College of Radiologists (Great Britain))  07 2018 
 - 418-426 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-2981 
<br/><br/><label>Standard No.: </label>10.1016/j.clon.2018.02.067  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Capecitabine--administration & dosage<br/>Chemoradiotherapy--adverse effects<br/>Cisplatin--administration & dosage<br/>Cohort Studies<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Gastrointestinal Diseases--epidemiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Nelfinavir--administration & dosage<br/>Pancreatic Neoplasms--therapy<br/>Prospective Studies<br/>Radiation Injuries--epidemiology<br/>Radiotherapy--adverse effects<br/>Risk Factors<br/>Stomach--radiation effects<br/>Gemcitabine